Kusajili – Clinical trials directory

Result of your search per sponsor: Merck Serono International, An affiliate of Merck KGaA, Darmstadt, Germany

Woman and Man Max 99 years
Merck Serono International, An affiliate of Merck KGaA, Darmstadt, Germany Update Il y a 4 ans

A Phase II/III, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of atacicept in combination with corticosteroids and sequential therapy with cyclophosphamide and azathioprine in subjects with lupus nephritis PRIMARY The primary objective of this trial is to evaluate the efficacy of atacicept compared to placebo in subjects with active LN who are receiving corticosteroids and sequential therapy with cyclop...

Country None
organs None
Specialty None

Closed trial

More information